Comparison of the Effectiveness of Oral Hygiene Motivation Methods Among Dentistry and Psychology Students
NCT07917286, Not applicable, Completed, Cyprus Health and Social Sciences University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Comparison of the Effectiveness of Oral Hygiene Motivation Methods Among Dentistry and Psychology Students | ClinicalTrials.gov |
| NCT number | NCT07917286 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 120 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Cyprus Health and Social Sciences University | ClinicalTrials.gov |
| Conditions | Oral Hygiene Motivation, Oral Hygiene, Dental Plaque | ClinicalTrials.gov |
| Interventions | Verbal Motivation, Model Demonstration, Plaque Disclosing | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Plaque Index (Silness-Löe) from Baseline to Three Weeks | Baseline (T0) and 3 weeks after intervention (T1) | Dental plaque accumulation was assessed using the Silness-Löe Plaque Index (1964). The buccal/facial, lingual, mesial, and distal surfaces of all evaluable teeth, excluding third molars, were scored on a scale from 0 (no plaque) to 3 (abundant plaque accumulation). The mean score across evaluated sites was calculated for each participant. Change was calculated as the three-week score minus the baseline score (T1-T0). Negative values indicate a reduction in plaque accumulation. | ClinicalTrials.gov |
| Primary | Change in Gingival Index (Löe-Silness) from Baseline to Three Weeks | Baseline (T0) and 3 weeks after intervention (T1) | Gingival inflammation was assessed using the Löe-Silness Gingival Index (1963). The distofacial papilla, facial gingival margin, mesiofacial papilla, and lingual gingival margin of all evaluable teeth, excluding third molars, were scored on a scale from 0 (normal gingiva) to 3 (severe inflammation). The mean score across evaluated sites was calculated for each participant. Change was calculated as the three-week score minus the baseline score (T1-T0). Negative values indicate a reduction in gingival inflammation. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)